Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Becton Dickinson (NY:BDX)

180.84 +9.16 (+5.34%)
Streaming Delayed Price Updated: 1:05 PM EST, Feb 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Becton Dickinson

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Biden's New Tariffs On Chinese Imports Are A 'Clear Giveaway' To These Two Tesla Rivals, Jim Cramer Says: 'I Like This Policy' ↗
Jim Cramer has highlighted the potential benefits for U.S. automakers, particularly Ford and General Motors, following the Biden administration's decision to impose substantial tariffs on Chinese... 
Via Benzinga
Topics World Trade
News headline image
MarketBeat Week in Review – 4/29 - 5/3
Apple, Amgen, and a weak jobs report helped move the market higher as investors temporarily looked past the possibility of no interest rate cuts in 2024 
Via MarketBeat
Topics Economy Stocks
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Becton & Dickinson 'Is Well On Its Way To Achieving 2025 Commitments,' Analyst Optimistic On Outlook ↗
BD reports Q2 sales of $5.04 billion, up 4.6% Y/Y. BD Medical, Life Sciences, and Interventional segments show growth. Guidance was raised for 2024 sales, and EPS was adjusted. William Blair rates BDX... 
Via Benzinga
News headline image
Looking Into Becton Dickinson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Peering Into Becton Dickinson's Recent Short Interest ↗
 
Via Benzinga
News headline image
Peering Into Becton Dickinson's Recent Short Interest ↗
 
Via Benzinga
News headline image
BDX Stock Earnings: Becton, Dickinson Beats EPS, Beats Revenue for Q2 2024 ↗
BDX stock results show that Becton, Dickinson beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
News headline image
How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025? ↗
Curious to know how much these dividend aristocrats could grow in the next year? Here's the answer for several well-known shares. 
Via InvestorPlace
News headline image
Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows ↗
Want quality picks and reliable income at a discount? Check out these Dividend Aristocrats trading at 52-week lows. 
Via InvestorPlace
News headline image
AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement ↗
AngioDynamics resolves decade-long patent litigation with Becton, Dickinson in landmark settlement, streamlining legal expenses and marking a significant milestone for the company. 
Via Benzinga
Topics Intellectual Property
News headline image
Becton Dickinson Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) ↗
 
Via Benzinga
News headline image
Earnings Preview For Becton, Dickinson ↗
 
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Becton Dickinson Stock In The Last 20 Years ↗
 
Via Benzinga
News headline image
Should You Buy Solventum (SOLV) Stock After the 3M Spinoff? ↗
Although 3M shareholders have reason to dump the Solventum spinoff, SOLV stock could be intriguing at the right price. 
Via InvestorPlace
News headline image
Jim Cramer Says Don't Sell This Beauty Brand, Believes KKR And Blackstone 'Can Make More Money' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer sang the praises of Energy Transfer LP (NYSE: ET), which posted better-than-expected earnings 
Via Benzinga
News headline image
Becton, Dickinson And Co. Dividend Stock Analysis ↗
Becton, Dickinson, and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs, and other settings. 
Via Talk Markets
News headline image
FDA Probe On China-Made Syringes: Becton Dickinson Boosts US Syringe Output Following Concerns ↗
BD boosts U.S. production of medical syringes following FDA concerns over Chinese-made syringes. Learn how BD addresses patient care continuity amid ongoing quality probe. 
Via Benzinga
News headline image
10 Big-Name Stocks Near 52-Week Lows: Are They A Buy? ↗
Over the past twelve months a number of big named companies have been near or below their 52 week low price. Each week we’ll take a look at some of the biggest names currently close to their 52 week... 
Via Talk Markets
News headline image
Peeling Back The Layers: Exploring Becton Dickinson Through Analyst Insights ↗
 
Via Benzinga
News headline image
7 Robotic Surgery Stocks to Buy for the Future of Healthcare ↗
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033. 
Via InvestorPlace
News headline image
3 Dividend Kings of Healthcare Stocks to Buy Hand Over Fist in March ↗
These are some of the best-performing stocks in what's arguably society's most important industry. 
Via The Motley Fool
News headline image
3 Stocks to Buy at 52-Week Lows: March 4 Edition ↗
Sometimes a gem can get tossed in the trash, which is what you will find with these three stocks to buy at 52-week lows. 
Via InvestorPlace
News headline image
Get Paid While You Wait: 7 Dividend Aristocrats to Buy Now ↗
Worried about an upcoming market correction? These seven Dividend Aristocrats are a safe harbor which offer great income streams. 
Via InvestorPlace
News headline image
Medical Device Maker Becton Dickinson's Q1 Earnings: Here's Why This Analyst Is Bullish On Long-Term Prospects ↗
BD exceeds expectations with Q1 2024 adjusted EPS of $2.68 (vs $2.40 consensus). William Blair maintains a positive outlook, confident in BD's progress towards its 2025. 
Via Benzinga
News headline image
Earnings Scheduled For February 1, 2024 ↗
Companies Reporting Before The Bell • ING Groep (NYSE:ING) is expected to report earnings for its fourth quarter. • Shell (NYSE:SHEL) is likely to report quarterly earnings at $1.81 per share on... 
Via Benzinga
News headline image
Biotech And Medtech Portfolio Notes On A Fed Day ↗
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
News headline image
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst ↗
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
News headline image
Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would back Moderna, Inc. (NASDAQ: MRNA) here. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.